Effect of aspirin use on thiazolidinediones and cardiovascular events

JAMA

Volumn 299, Issue 13, 2008, Pages 1539-

  Konstantinopoulos, Panagiotis A ^a   Karamouzis, Michalis V ^b   Papavassiliou, Athanasios G ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; PLACEBO; PROSTACYCLIN; THROMBOXANE A2; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DOWN REGULATION; DRUG EFFECT; ENZYME INHIBITION; ENZYME REGULATION; FATTY ACID SYNTHESIS; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOSIS; VASCULAR ENDOTHELIUM; DRUG INTERACTION; NOTE;

ASPIRIN; CARDIOVASCULAR DISEASES; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; HUMANS; HYPOGLYCEMIC AGENTS; PLATELET AGGREGATION INHIBITORS; THIAZOLIDINEDIONES;

EID: 41649092951     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.13.1539-a     Document Type: Letter

References (5)

1. Lipscombe LL, Gomes T, Levesque LE, Hux JE, Juurlink DN, Alter DA. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA. 2007;298(22):2634-2643.
2. Dormandy JA, Charbonnel B, Eckland DJ, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366(9493):1279-1289.
3. Mendez M, LaPointe MC. PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes. Hypertension. 2003;42(4):844-850.
4. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? meta-analysis of randomised trials. BMJ. 2006;332(7553):1302-1308.
5. Konstantinopoulos PA, Lehmann DF. The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confounding. J Clin Pharmacol. 2005;45(7):742-750.